FilingReader Intelligence
Legend Biotech's sales soar; GenScript associate announces results
March 11, 2025 at 05:01 PM UTC•By FilingReader AI
Legend Biotech Corporation (LEGN), a 47.51% owned associate of Genscript Biotech Corp (HKEX:1548), announced its financial results for the fourth quarter and year ended December 31, 2024. CARVYKTI® net trade sales reached approximately $334 million for the quarter and $963 million for the full year.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
HKEX:1548•Hong Kong Exchange
News Alerts
Get instant email alerts when Genscript Biotech Corp publishes news
Free account required • Unsubscribe anytime